clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemia

Professor Anna Schuh, director of molecular diagnostics and consultant haematologist, University of Oxford and Oxford University Hospitals NHS Trust. Received educational grants and honoraria for advisory boards from the company.

Professor Guy Pratt, honorary professor of haematology and consultant haematologist, University Hospitals Birmingham NHS Foundation Trust. Did not declare any interests.

Dr Karthik Ramasamy, associate professor of haematology and consultant haematologist, University of Oxford and Oxford University Hospitals NHS Trust. Received honoraria from the company for attending advisory boards.

Dr Bela Wrench, group leader in leukaemia biology and honorary consultant in haemato-oncology, Barts Cancer Institute. Did not declare any interests.

Dr John Riches, consultant haemato-oncologist, Barts Cancer Institute. Did not declare any interests.